Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.680
-0.030 (-1.75%)
At close: Jan 23, 2026, 4:00 PM EST
1.680
0.00 (0.00%)
After-hours: Jan 23, 2026, 4:27 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $10.34 million as of January 23, 2026. Its market cap has decreased by -77.53% in one year.
Market Cap
10.34M
Enterprise Value
764.69K
1-Year Change
-77.53%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $10.34M, a decrease of -98.36%. That is a compound annual growth rate of -57.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 10.53M | 3.64% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IN8bio | 9.96M |
| Aptevo Therapeutics | 9.81M |
| BioRestorative Therapies | 9.76M |
| Pulmatrix | 9.75M |
| MetaVia | 9.62M |
| Ernexa Therapeutics | 9.58M |
| Alzamend Neuro | 9.20M |
| BioVie | 9.20M |